Genpro Research’s Post

Learn how AI-assisted #scopingreview helped researchers rapidly identify five #evidencebased clinical practice guidelines across three interventional categories for #tinnitus. Read the abstract here > https://lnkd.in/gpBB4x3M. #lifesciencesAI #metaanalysis #MAIA

AI for Real-World Studies in Internal Medicine Natural Language Processing (NLP) is revolutionizing how we approach Real-World Evidence (RWE) in internal medicine. By transforming unstructured clinical data into meaningful insights, these type of technologies enable clinicians and researchers to analyze patient outcomes in real-world settings. This approach enhances evidence-based decision-making, personalizes treatment strategies and accelerates medical research, ultimately improving patient care. The future of internal medicine is data-driven and AI-powered! #DataScience #HealthTech #MachineLearning #HealthcareAI #MedicalInnovation #PrecisionMedicine #HealthData #AIRevolution #TechInHealthcare #ClinicalInnovation #BigData #AITransformation

Did you know 85% of clinical trials fail to recruit enough participants? Horizon Trials is changing that by using our AI-powered platform to match patients with trials that perfectly fit their conditions—faster, smarter, and more accurately than ever before. Get connected to trials that offer not only potential treatments but also hope. Your participation can change the future of medicine—and we’re here to help you find the perfect match! #HorizonTrials #ClinicalTrials

Inspiring career in pharmaceutical industry…

Clinical research is crucial for advancing medical knowledge and improving patient outcomes, yet over-recruiting patients remains a significant challenge. This leads to inflated costs and inefficient resource use. A TrialKey.ai analysis of a Focal Segmental Glomerulosclerosis (FSGS) study recommended enrolling 200 participants instead of 286. This optimised number increased the trial’s success likelihood by 28% and would've resulted in significant cost savings. The original cost of enrolling 286 participants was approximately $11,615,032, while enrolling 200 participants would have saved $3,492,632, reducing the total cost to $8,122,400. By leveraging TrialKey.ai's advanced algorithms and real-world evidence, researchers can achieve optimal participant numbers, mitigate overspending, and enhance trial success rates. Keen to learn more about a particular trial? Book a demo today and let us know an NCT you're interested in https://lnkd.in/g9rJtUBm Read more here: https://lnkd.in/g2iDE2uj #trialkey #opyl #patientenrollment #clinicaltrials 

Level up your clinical decision support with Dyna AI for DynaMedex! Visit us at Family Medicine Midwest 2024 to see how our innovative solutions are transforming clinical decision support, bringing you evidence-based clinical information faster than ever. #FMM2024 #DynaAI #HealthcareInnovation

Putting Patients First: The Power of Patient Centric Trials In the realm of clinical trials, placing patients at the forefront is not just a principle; it's a powerful paradigm shift that drives better outcomes. According to a study from the National Library of Medicine (NLM) of Medicine, patient-centric approaches are pivotal in designing and conducting clinical trials across all phases. By prioritizing patient experiences and outcomes, we create trials that are more inclusive, engaging, and ultimately more successful. In phase 1, this means involving patients in #trialdesign , ensuring protocols are realistic and respectful of their needs. In later stages, patient-centricity fosters better communication, transparency, and support throughout the trial journey. Moreover, patient-centric trials extend beyond clinical settings, embracing technology to enhance remote monitoring, virtual visits, and data collection. This not only improves trial efficiency but also expands access for patients who may face geographical or mobility barriers. Ultimately, patient-centric trials are about more than just #datacollection ; they're about honoring the human experience and journeying alongside patients toward better health. At Clinixir, we're committed to leading the way in patient-centric research, because we believe that when patients thrive, science thrives. Clinixir, a leading #contractresearchorganization in #Thailand, offers comprehensive #clinicalresearch solutions for medical innovations. Contact us at [email protected] or https://lnkd.in/gBEu96q2 for more information. Visit www.clinixir.com to learn more about our services.

Intermittent fasting shows promise in promoting brain health and potentially reducing the risk of vascular dementia through various mechanisms! It was a pleasure writing this paper, on the topic that I worked on for my PhD!

Yesterday, Michael Barron, our Health Policy and Regulatory Affairs Specialist, had the opportunity to represent NAPT in Washington, DC, at the AI Demonstration Day, sponsored by AdvaMed. This prestigious event, honorarily co-hosted by Senator Martin Heinrich (D-NM) and Senator Mike Rounds (R-SD), brought together leading healthcare companies, government officials, and industry experts to showcase the latest AI-enabled medical devices and technologies. Michael engaged in important conversations about patient accessibility to innovation and the transformative impact of AI on healthcare. The discussions highlighted how AI is revolutionizing clinical trials, enhancing disease detection and diagnosis, and improving patient care. Additionally, the potential for AI applications in proton therapy was a key topic, showcasing how AI can optimize treatment planning, improve precision in targeting tumors, and ultimately enhance patient outcomes. We're excited about the potential of AI to drive advancements in healthcare and proton therapy, and we are proud to be part of this important dialogue. Stay tuned as we continue to advocate for innovative technologies that improve patient outcomes! #HealthcareInnovation #ArtificialIntelligence #ProtonTherapy #HealthPolicy #AIinHealthcare 

We are very excited to share: OneHealth, a rapidly growing independent primary care provider group, and healthPrecision have announced a strategic partnership to deliver Modern Primary Care by providing the Medical Brain AI Clinical Assistant to their growing number of patients and providers. The partnership between One Health and healthPrecision facilitates a fundamental shift to a new model of care, Modern Primary Care. Medical Brain AI Clinical Assistant is a critical component of Modern Primary Care, automating care in real-time with patient-centric clinical decision support and real-time care orchestration. The Medical Brain will be helping hundreds of providers, and their patients shift to the Modern Primary Care delivery platform, achieving better outcomes at lower total cost of care while minimizing burden on providers and enabling patients’ immediate access to care, 24/7. “At healthPrecision, our mission is to harness the power of AI to transform healthcare delivery and improve patient outcomes. We’re thrilled to partner with One Health, a visionary organization that shares our commitment to innovation and excellence in care.”– Eyal Ephrat, MD, CEO and Co-Founder of healthPrecision. #ai #aiclinicalassistant #healthtech #aiinhealthcare #healthcareai #modernprimarycare #onehealth https://lnkd.in/eMsuP3e3